CRSP logo

CRISPR Therapeutics AG (CRSP) Net margin

annual net margin:

-1046.43%-1004.91%(-2420.30%)
December 31, 2024

Summary

  • As of today (June 22, 2025), CRSP annual net profit margin is -1046.43%, with the most recent change of -1004.91% (-2420.30%) on December 31, 2024.
  • During the last 3 years, CRSP annual net margin has fallen by -1087.79% (-2630.05%).
  • CRSP annual net margin is now -2630.05% below its all-time high of 41.36%, reached on December 31, 2021.

Performance

CRSP Net margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPprofitability metrics

Quarterly net margin:

N/A
March 31, 2025

Summary

  • CRSP quarterly net profit margin is not available.

Performance

CRSP Quarterly net margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCRSPprofitability metrics

Net margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

CRSP Net margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2420.3%-
3 y3 years-2630.1%-
5 y5 years-4632.0%-

CRSP Net margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2630.1%+99.3%
5 y5-year-2630.1%+99.3%
alltimeall time-2630.1%+99.3%

CRSP Net margin History

DateAnnualQuarterly
Dec 2024
-1046.43%(+2420.3%)
-106.60%(-338.6%)
Dec 2023
-41.52%(-100.0%)
44.67%(-140.2%)
Jun 2023
-
-111.06%(+109.3%)
Mar 2023
-
-53.07%(-100.0%)
Dec 2022
-149.12K%(<-9900.0%)
-1.84M%(+892.5%)
Sep 2022
-
-185.69K%(+57.9%)
Jun 2022
-
-117.62K%(+16.8%)
Mar 2022
-
-100.68K%(+8701.9%)
Dec 2021
41.36%(-100.1%)
-1143.89%(-97.0%)
Sep 2021
-
-38.65K%(<-9900.0%)
Jun 2021
-
84.34%(-100.2%)
Mar 2021
-
-56.02K%(+1.5%)
Dec 2020
-64.25K%(<-9900.0%)
-55.17K%(-11.7%)
Sep 2020
-
-62.46K%(-65.5%)
Jun 2020
-
-181.04K%(+307.6%)
Mar 2020
-
-44.41K%(<-9900.0%)
DateAnnualQuarterly
Dec 2019
23.09%(-100.4%)
39.66%(-39.3%)
Sep 2019
-
65.32%(-100.4%)
Jun 2019
-
-16.89K%(+14.4%)
Mar 2019
-
-14.76K%(-64.3%)
Dec 2018
-5281.08%(+3067.3%)
-41.38K%(+359.4%)
Sep 2018
-
-9007.28%(+155.3%)
Jun 2018
-
-3527.57%(+69.3%)
Mar 2018
-
-2083.95%(<-9900.0%)
Dec 2017
-166.74%(-62.9%)
0.44%(-100.0%)
Sep 2017
-
-1035.06%(+66.1%)
Jun 2017
-
-622.98%(-21.6%)
Mar 2017
-
-794.49%(-16.2%)
Dec 2016
-449.30%(-95.7%)
-
Sep 2016
-
-948.61%(-56.1%)
Jun 2016
-
-2158.99%(+21.7%)
Mar 2016
-
-1773.53%(-64.3%)
Dec 2015
-10.46K%
-4974.09%

FAQ

  • What is CRISPR Therapeutics AG annual net profit margin?
  • What is the all time high annual net margin for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG annual net margin year-on-year change?
  • What is the all time high quarterly net margin for CRISPR Therapeutics AG?

What is CRISPR Therapeutics AG annual net profit margin?

The current annual net margin of CRSP is -1046.43%

What is the all time high annual net margin for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual net profit margin is 41.36%

What is CRISPR Therapeutics AG annual net margin year-on-year change?

Over the past year, CRSP annual net profit margin has changed by -1004.91% (-2420.30%)

What is the all time high quarterly net margin for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly net profit margin is 84.34%
On this page